Cantourage Group SE (XTER:HIGH) EBIT: €0.05 Mil (TTM As of Jun. 2025)


XTER:HIGH Cantourage Group SE XTER:HIGH
22 GF Score
Price €6.26
! 4 Warning Signs
View Full Analysis

What is Cantourage Group SE EBIT?

Cantourage Group SE XTER:HIGH +3.64% 22 EBIT is €0.05 Mil as of Jun. 2025. GuruFocus rates XTER:HIGH with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

Cantourage Group SE's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2025 was €0.05 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2025 was €0.05 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cantourage Group SE's annualized ROC % for the quarter that ended in Jun. 2025 was 0.16%. Cantourage Group SE's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2025 was 2.58%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cantourage Group SE's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2025 was 0.06%.

Cantourage Group SE  (XTER:HIGH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cantourage Group SE's annualized ROC % for the quarter that ended in Jun. 2025 is calculated as:

ROC % (Q: Jun. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Jun. 2025 ))/ count )
=0.088 * ( 1 - 18.18% )/( (44.716 + 44.986)/ 2 )
=0.0720016/44.851
=0.16 %

where

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=45.476 - 0.491 - ( 0.269 - max(0, 0.494 - 4.804+0.269))
=44.716

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=45.474 - 0.45 - ( 0.038 - max(0, 0.462 - 3.526+0.038))
=44.986

Note: The Operating Income data used here is two times the semi-annual (Jun. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Cantourage Group SE's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Jun. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0.09/( ( (0 + max(3.965, 0)) + (0 + max(3.023, 0)) )/ 2 )
=0.09/( ( 3.965 + 3.023 )/ 2 )
=0.09/3.494
=2.58 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.459 + 0 + 0) - (0.491 + 0 + 0.003)
=3.965

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2.942 + 0 + 0.543) - (0.45 + 0 + 0.012)
=3.023

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cantourage Group SE's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2025 )
=0.045/73.791
=0.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE EBIT Related Terms

Cantourage Group SE EBIT Historical Data

* Premium members only.

The historical data trend for Cantourage Group SE's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE EBIT Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
-0.18 -0.59 -0.95 0.03 -4.32

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Jun25
EBIT Get a 7-Day Free Trial Premium Member Only 0.03 0.03 -4.35 0.21 0.05

XTER:HIGH vs ZTS, UTHR, VTRS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantourage Group SE EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's EV-to-EBIT falls into.


XTER:HIGH
22GF Score
Cantourage Group SE XTER:HIGH
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cantourage Group SE EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €0.05 Mil mean?
Cantourage Group SE (XTER:HIGH) has a EBIT of €0.05 Mil as of Jun. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cantourage Group SE.
Is Cantourage Group SE's EBIT too high?
Cantourage Group SE's current EBIT is €0.05 Mil. Overall, Cantourage Group SE has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's EBIT compare to ZTS and UTHR?
Cantourage Group SE's EBIT of €0.05 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cantourage Group SE. Cantourage Group SE's current EBIT is €0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (XTER:HIGH) has a current EBIT of €0.05 Mil. The current EBIT is €0.05 Mil. Cantourage Group SE's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Cantourage Group SE (XTER:HIGH), the current EBIT is €0.05 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantourage Group SE Business Description

Address Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
22GF Score

Get the complete analysis for XTER:HIGH

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.26
Price